[{"Assets_0_FY_USD":3454300000.0,"EarningsPerShareBasic_1_FY_USD":0.49,"EarningsPerShareBasic_4_FY_USD":0.88,"EarningsPerShareDiluted_1_FY_USD":0.49,"EarningsPerShareDiluted_4_FY_USD":0.87,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":299500000.0,"NetIncomeLoss_1_FY_USD":61800000.0,"NetIncomeLoss_4_FY_USD":109800000.0,"StockholdersEquity_0_FY_USD":723500000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":126737785.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":124954248.0,"Ticker":"CTLT","CIK":"1596783","name":"CATALENT, INC.","OfficialName":"Catalent Inc. Common Stock","form":"10-K","period":"20170630","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"17076283108.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20170828"}]